Viking Therapeutics (VKTX) Rockets 35.7% After Weight Loss Drug Trial — What’s The Selling Point?

Reported by Yahoo Finance · Published 23 Sep 2026, 6:37 AM MYT (1 d ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Thailand eyes $80 billion in semiconductor investment by 2050 under new strategy 51 min ago The data proves it: Bitcoin doesn't care about rising bond yields over long-term 54 min ago China confirms first AI talks with U.S. have taken place, hints at trade truce extension 1 hr ago EU financial watchdogs warn quantum computing poses imminent threat to blockchain encryption 1 hr ago Dollar hovers near 2-month peak, Swiss Franc falls, Norwegian crown rises 1 hr ago ‘We made a bad, bad decision’: I learned the hard way how to manage my aging father’s money 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Viking Therapeutics (VKTX) Rockets 35.7% After Weight Loss Drug Trial — What’s The Selling Point?

Summary

More in Markets

China confirms first AI talks with U.S. have taken place, hints at trade truce extension

‘We made a bad, bad decision’: I learned the hard way how to manage my aging father’s money

Meta gets price-target boost as JPMorgan says Muse agent has potential to become the top AI application since ChatGPT

8 grassroots porchfests for experiencing free live music and neighborhood culture

Selena Gomez sells her Encino mansion, once owned by Tom Petty, for $5.4 million

The market is pricing in too many Fed hikes, says the former Dallas Fed chief